Metabolic Syndrome and Coronary Heart Disease in South Asians, African-Caribbeans and White Europeans: a UK Population-based Cross-sectional Study

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2005 Mar 11

PMID 15759110

Citations 63

Authors

T Tillin

N Forouhi

D G Johnston

P M McKeigue

N Chaturvedi

I F Godsland

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The aim of this study was to study differences in the prevalence of the metabolic syndrome and its associations with prevalent CHD according to ethnicity and sex.

Methods: We performed a combined analysis of two population-based cross-sectional studies conducted between 1988 and 1991 that followed identical protocols. Participants (aged 40-69 years) comprised 2,346 Europeans (76% male), 1,711 South Asians (83% male) and 803 African-Caribbeans (57% male) resident in west London. Fasting blood, overnight urine collection, clinical and anthropometric measurements were performed. Clinical history or major ECG changes defined prevalent CHD. The metabolic syndrome was defined according to the criteria recommended by the World Health Organization (WHO) and the National Cholesterol Education Programme (NCEP).

Results: The prevalence of the metabolic syndrome was highest in South Asians (WHO, men 46%, women 31%; NCEP, men 29%, women 32%) and lowest in European women (WHO, 9%; NCEP, 14%). The prevalence of CHD was 10% in South Asian men, 9% in European men, 5-6% in African-Caribbeans and European women, and 2% in South Asian women. The metabolic syndrome was associated with prevalent CHD in European men [NCEP, odds ratio (OR)=1.6, 95% CI 1.2-2.4; WHO, OR=1.7, 95% CI 1.2-2.5] and South Asian men (NCEP, OR=2.1, 95% CI 1.5-3.1; WHO, OR=1.6, 95% CI 1.1-2.3). Associations with CHD were weaker in African-Caribbeans and were inconsistent among European women.

Conclusions/interpretation: The current definitions of the metabolic syndrome give an inconsistent picture of cardiovascular disease risk when applied to different ethnic groups within the UK. Prospective studies are needed to validate workable ethnic-specific definitions.

Citing Articles

Exploring the Relationship Between Different Obesity Metabolism Indices and Hyperuricemia in Patients with Hypertension and Coronary Heart Disease.

Li Y, Yi S, Jiang W, Gong M Diabetes Metab Syndr Obes. 2024; 17:3817-3832.

PMID: 39440026 PMC: 11495196. DOI: 10.2147/DMSO.S491255.

Ethnic differences in metabolic syndrome in high-income countries: A systematic review and meta-analysis.

Adjei N, Samkange-Zeeb F, Boakye D, Saleem M, Christianson L, Kebede M Rev Endocr Metab Disord. 2024; 25(4):727-750.

PMID: 38598068 PMC: 11294386. DOI: 10.1007/s11154-024-09879-9.

Ethnic variations in metabolic syndrome components and their associations with the gut microbiota: the HELIUS study.

Balvers M, de Goffau M, van Riel N, van den Born B, Galenkamp H, Zwinderman K Genome Med. 2024; 16(1):41.

PMID: 38509598 PMC: 10953122. DOI: 10.1186/s13073-024-01295-7.

Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review.

Saccaro L, Aimo A, Panichella G, Sentissi O Front Psychiatry. 2024; 15:1343427.

PMID: 38501085 PMC: 10944869. DOI: 10.3389/fpsyt.2024.1343427.

Metabolic Syndrome and Chronic Disease Risk in South Asian Immigrants: A Review of Prevalence, Factors, and Interventions.

Mahadevan M, Bose M, Gawron K, Blumberg R Healthcare (Basel). 2023; 11(5).

PMID: 36900725 PMC: 10000781. DOI: 10.3390/healthcare11050720.

References

Laaksonen D, Lakka H, Niskanen L, Kaplan G, Salonen J, Lakka T . Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002; 156(11):1070-7. DOI: 10.1093/aje/kwf145. View

Mattix H, Hsu C, Shaykevich S, Curhan G . Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002; 13(4):1034-1039. DOI: 10.1681/ASN.V1341034. View

Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M . Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24(4):683-9. DOI: 10.2337/diacare.24.4.683. View

Godsland I, Jeffs J, Johnston D . Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia. 2004; 47(7):1157-1166. DOI: 10.1007/s00125-004-1454-z. View

Chaturvedi N, McKeigue P, Marmot M . Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia. 1994; 37(8):765-72. DOI: 10.1007/BF00404333. View

Matsuda M, DeFronzo R . Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999; 22(9):1462-70. DOI: 10.2337/diacare.22.9.1462. View

Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K . Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004; 164(10):1066-76. DOI: 10.1001/archinte.164.10.1066. View

Chaturvedi N, McKeigue P, Marmot M . Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension. 1993; 22(1):90-6. DOI: 10.1161/01.hyp.22.1.90. View

McKeigue P, Shah B, Marmot M . Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991; 337(8738):382-6. DOI: 10.1016/0140-6736(91)91164-p. View

10.

Sattar N, Gaw A, Scherbakova O, Ford I, OReilly D, Haffner S . Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003; 108(4):414-9. DOI: 10.1161/01.CIR.0000080897.52664.94. View

11.

Ford E, Giles W . A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003; 26(3):575-81. DOI: 10.2337/diacare.26.3.575. View

12.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

13.

Ridker P, Buring J, Cook N, Rifai N . C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. DOI: 10.1161/01.cir.0000055014.62083.05. View

14.

Hunt K, Resendez R, Williams K, Haffner S, Stern M . National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004; 110(10):1251-7. DOI: 10.1161/01.CIR.0000140762.04598.F9. View

15.

Balkau B, Charles M, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin J . Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002; 28(5):364-76. View

16.

Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288(21):2709-16. DOI: 10.1001/jama.288.21.2709. View

17.

Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R . Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care. 2003; 26(4):1251-7. DOI: 10.2337/diacare.26.4.1251. View

18.

Reaven G . Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37(12):1595-607. DOI: 10.2337/diab.37.12.1595. View

19.

Balkau B, Charles M . Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16(5):442-3. DOI: 10.1046/j.1464-5491.1999.00059.x. View

20.

Wild S, McKeigue P . Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ. 1997; 314(7082):705-10. PMC: 2126166. DOI: 10.1136/bmj.314.7082.705. View